Post-ASCO Update on Breast Cancer

The Abramson Cancer Center of the University of Pennsylvania
Last Modified: May 17, 2005

Conference Dates: June 14, 2005
Conference Location: Maggiano's Little Italy Restaurant, 1201 Filbert Street, Philadelphia, PA

Sponsoring Group: University of Pennsylvania School of Medicine/Continuing Medical Education

Conference Brochure: Post-ASCO Update on Breast Cancer [PDF]

Conference Objectives: At the end of the conference participants will be able to:

  1. Define chemotherapy regimens for early-stage and metastatic breast cancer
  2. Define the role of trastuzumab in the adjuvant therapy of breast cancer
  3. Describe new clinical data for the use of hormonal therapy in breast cancer
  4. Describe the epidemiology & natural history of breast cancer
  5. Identify current surveillance strategies & prevention for breast cancer
  6. Identify the role of genomics in selecting therapy

Who Should Attend: medical oncologists, radiation oncologists, hematology/oncology fellows, oncology nurses, and other health care professionals involved in the treatment of patients with breast cancer

Registration Information:

Name:
Academic Degree:
Medical Specialty:
Affiliation:
Street Address:
City:
State: ZIP Code:
Country:
Email Address:
Daytime Telephone #:
Fax #:

Conference Fees: There is no fee for this conference.

Continuing Education: Yes

Related News

ASCO Recommends Adjuvant Endocrine Therapy Extension

May 29, 2014

Modest survival advantage, lower recurrence seen with therapy for 10 years versus five years


ASCO Urges Breast Cancer Chemoprevention Discussion

Jul 10, 2013

ASCO encourages providers to speak to women at increased risk about the benefits, hazards


ASCO Updates Guidelines for Hepatitis B Screening in Cancer

May 15, 2015

Screening urged for patients with risk factors for infection, receiving cancer tx linked to reactivation